SCHEMBL5567258

SCHEMBL5567258

CN(C)CC(C)(C)C(N)CC(=O)N1CC(C)(C)c2ccc(N3C(=O)N(Cc4ccnc5ccccc45)C(C)(C)C3=O)cc21

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 13/20 0.47
ROCK1 Q13464 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1130652 0.88 IGF1R (0.47) IGF1RROCK1AR
SCHEMBL1130931 0.87 IGF1R (0.51) IGF1RROCK1AR
SCHEMBL1131107 0.84 IGF1R (0.46) IGF1RROCK1AR
SCHEMBL1130395 0.83 IGF1R (0.54) IGF1RAR
SCHEMBL1130958 0.83 IGF1R (0.54) IGF1R
SCHEMBL1130662 0.83 IGF1R (0.49) IGF1RROCK1AR
SCHEMBL1130034 0.82 IGF1R (0.49) IGF1RROCK1AR
SCHEMBL1130711 0.82 IGF1R (0.49) IGF1RROCK1AR
SCHEMBL1130513 0.81 IGF1R (0.49) IGF1RROCK1AR
SCHEMBL1130519 0.80 IGF1R (0.48) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773808-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2007-04-18 EP disclosed
WO-2006010641-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2006-02-02 WO disclosed